找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Case-Based Gynecological Oncology; Kavita Singh,Bindiya Gupta Book 2023 The Editor(s) (if applicable) and The Author(s), under exclusive l

[復(fù)制鏈接]
樓主: 磨損
21#
發(fā)表于 2025-3-25 06:05:53 | 只看該作者
Epithelial Ovarian Cancer: High Grade SerousEpithelial ovarian cancer mainly presents in advanced stage. In recent years, treatment has been revolutionized by changes in surgical and medical management, introduction of targeted therapies and biomarker directed therapies. This change in the treatment paradigm has had substantially improved survival statistics.
22#
發(fā)表于 2025-3-25 10:39:01 | 只看該作者
Recurrent Ovarian CancerRecurrent ovarian cancer may be sensitive to platinum or platinum resistant. Management includes a combination of chemotherapy and targeted therapy. Secondary debulking surgery can be done in select cases where it is possible to achieve complete cytoreduction..This chapter will discuss clinical scenarios of recurrent ovarian cancer.
23#
發(fā)表于 2025-3-25 14:05:11 | 只看該作者
24#
發(fā)表于 2025-3-25 16:56:49 | 只看該作者
25#
發(fā)表于 2025-3-25 20:14:28 | 只看該作者
26#
發(fā)表于 2025-3-26 02:03:09 | 只看該作者
27#
發(fā)表于 2025-3-26 05:21:12 | 只看該作者
28#
發(fā)表于 2025-3-26 11:27:07 | 只看該作者
Metastatic Ovarian Canceristochemistry especially using CK7 and CK20 are the most commonly used antigens in differentiating between primary and metastatic ovarian tumours. Genetic testing is crucial for counselling and tailoring management. Treatment is mainly palliative chemotherapy while in select cases metastatectomy or cytoreductive surgery may be useful.
29#
發(fā)表于 2025-3-26 13:51:58 | 只看該作者
Borderline Ovarian Tumours: Early and Advance Stage: Serous, Mucinous, Micro Invasive Cancer, Invasi mild nuclear atypia without destructive stromal invasion. These account for 10–15% of all epithelial tumours. The most common subtypes are serous and mucinous tumours. Surgery is the mainstay of management and these are associated with better prognosis than invasive carcinomas.
30#
發(fā)表于 2025-3-26 19:31:56 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 20:54
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
三原县| 英超| 于田县| 武安市| 孙吴县| 冕宁县| 京山县| 高邑县| 开远市| 广昌县| 四平市| 朔州市| 察雅县| 增城市| 工布江达县| 蒙自县| 临邑县| 永城市| 搜索| 台州市| 中卫市| 广河县| 乌海市| 平定县| 阿鲁科尔沁旗| 武乡县| 玉田县| 东乡族自治县| 邯郸县| 任丘市| 澳门| 环江| 吴堡县| 共和县| 万源市| 班戈县| 广元市| 建德市| 阳东县| 镇远县| 汝城县|